Clinical trial
A Multi-center, Prospective, Randomized, Double-blind, Flexible-dose, Placebo-controlled, Parallel Group Clinical Trial of Sildenafil Oral Film 25 mg, 50 mg, 75 mg and 100 mg for the Treatment of Erectile Dysfunction (ED)
NCT05490680 is registered in ClinicalTrials.gov with IBSA Institut Biochimique SA as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Prospective, Randomized, Double-blind, Flexible-dose, Placebo-controlled, Parallel Group Clinical Trial of Sildenafil Oral Film 25 mg, 50 mg, 75 mg and 100 mg for the Treatment of Erectile Dysfunction (ED)
- Lead sponsor
- IBSA Institut Biochimique SA
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- January 26, 2024
- Completion date
- December 9, 2024
- Enrollment
- 488 (actual)
- Sites
- 18
Conditions
As the registry lists them; a condition with its own page is linked.